- Home
- SBET vs ATYR Comparison
SBET vs ATYR Comparison
Compare SBET & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBET
- ATYR
- Stock Information
- Founded
- SBET 1995
- ATYR 2005
- Country
- SBET United States
- ATYR United States
- Employees
- SBET N/A
- ATYR N/A
- Industry
- SBET Computer Software: Prepackaged Software
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SBET Technology
- ATYR Health Care
- Exchange
- SBET Nasdaq
- ATYR Nasdaq
- Market Cap
- SBET 618.0M
- ATYR 535.0M
- IPO Year
- SBET 1997
- ATYR 2015
- Fundamental
- Price
- SBET $17.02
- ATYR $5.30
- Analyst Decision
- SBET
- ATYR Strong Buy
- Analyst Count
- SBET 0
- ATYR 5
- Target Price
- SBET N/A
- ATYR $23.25
- AVG Volume (30 Days)
- SBET 34.7M
- ATYR 4.3M
- Earning Date
- SBET 08-14-2025
- ATYR 11-06-2025
- Dividend Yield
- SBET N/A
- ATYR N/A
- EPS Growth
- SBET N/A
- ATYR N/A
- EPS
- SBET N/A
- ATYR N/A
- Revenue
- SBET $3,144,153.00
- ATYR N/A
- Revenue This Year
- SBET $858.54
- ATYR $478.72
- Revenue Next Year
- SBET $194.83
- ATYR $1,899.26
- P/E Ratio
- SBET N/A
- ATYR N/A
- Revenue Growth
- SBET N/A
- ATYR N/A
- 52 Week Low
- SBET $2.26
- ATYR $1.67
- 52 Week High
- SBET $124.12
- ATYR $7.29
- Technical
- Relative Strength Index (RSI)
- SBET 45.34
- ATYR 49.93
- Support Level
- SBET $14.29
- ATYR $5.08
- Resistance Level
- SBET $17.26
- ATYR $5.59
- Average True Range (ATR)
- SBET 1.13
- ATYR 0.39
- MACD
- SBET -0.05
- ATYR -0.01
- Stochastic Oscillator
- SBET 44.61
- ATYR 25.71
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.